These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19027146)

  • 1. Aggressive and complex surgery for advanced ovarian cancer: an economic analysis.
    Aletti GD; Podratz KC; Moriarty JP; Cliby WA; Long KH
    Gynecol Oncol; 2009 Jan; 112(1):16-21. PubMed ID: 19027146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
    Aletti GD; Dowdy SC; Podratz KC; Cliby WA
    Am J Obstet Gynecol; 2007 Dec; 197(6):676.e1-7. PubMed ID: 18060979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis.
    Greving JP; Vernooij F; Heintz AP; van der Graaf Y; Buskens E
    Gynecol Oncol; 2009 Apr; 113(1):68-74. PubMed ID: 19176236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
    Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD
    Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer.
    Aletti GD; Dowdy SC; Podratz KC; Cliby WA
    Gynecol Oncol; 2006 Feb; 100(2):283-7. PubMed ID: 16182350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery.
    Dainty L; Maxwell GL; Clarke-Pearson DL; Myers ER
    Gynecol Oncol; 2004 May; 93(2):366-73. PubMed ID: 15099947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical care of young women diagnosed with ovarian cancer: a population-based perspective.
    Tanner EJ; Zahurak ML; Bristow RE; Díaz-Montes TP
    Gynecol Oncol; 2008 Nov; 111(2):221-5. PubMed ID: 18786718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
    Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope CR; Wilson TO; Podratz KC; Cliby WA
    Obstet Gynecol; 2006 Jan; 107(1):77-85. PubMed ID: 16394043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
    Aletti GD; Santillan A; Eisenhauer EL; Hu J; Aletti G; Podratz KC; Bristow RE; Chi DS; Cliby WA
    Gynecol Oncol; 2007 Oct; 107(1):99-106. PubMed ID: 17602726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial.
    North RB; Kidd D; Shipley J; Taylor RS
    Neurosurgery; 2007 Aug; 61(2):361-8; discussion 368-9. PubMed ID: 17762749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of care in advanced ovarian cancer: the importance of provider specialty.
    Mercado C; Zingmond D; Karlan BY; Sekaris E; Gross J; Maggard-Gibbons M; Tomlinson JS; Ko CY
    Gynecol Oncol; 2010 Apr; 117(1):18-22. PubMed ID: 20106512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
    Chi DS; Eisenhauer EL; Zivanovic O; Sonoda Y; Abu-Rustum NR; Levine DA; Guile MW; Bristow RE; Aghajanian C; Barakat RR
    Gynecol Oncol; 2009 Jul; 114(1):26-31. PubMed ID: 19395008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN; Buttin BM; Powell MA; Gibb RK; Rader JS; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
    Cohn DE; Huh WK; Fowler JM; Straughn JM
    Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience.
    Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope RC; Wilson TO; Podratz KC; Cliby WA
    J Am Coll Surg; 2009 Apr; 208(4):614-20. PubMed ID: 19476798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of comprehensive surgical treatment in patients with ovarian cancer.
    Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM
    Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.